Each Extended Release capsule contains 50mg Diclofenac Potassium.
Non steroidal anti-inflammatory drug.
Diclofenac is eliminated through metabolism and subsequent urinary and biliary excretion of
the glucuronide and the sulfate conjugates of the metabolites. Little or no free unchanged diclofenac is excreted in the urine. Approximately 65% of the dose is excreted in the urine.
For treatment of primary dysmenorrhe.
For relief of mild to moderate pain.
For relief of the signs and symptoms of osteoarthritis.
For relief of the signs and symptoms of rheumatoid arthritis.
For treatment of pain or primary dysmenorrhea the recommended dosage is 50 mg 3 times daily. An initial dose of 100 mg of Adwiflam 50 ER, followed by 50mg doses, will provide better relief.
For the relief of osteoarthritis the recommended dosage is 100-150 mg/day in divided
For the relief of rheumatoid arthritis the recommended dosage is 150-200 mg/day in divided doses.
In patients with known hypersensitivity to diclofenac.
In patients who have experienced asthma, urticaria, or allergic- type reactions after taking aspirin or other NSAIDs.
Patients on prolonged corticosteroid therapy should have their therapy tapered slowly if a decision is made to discontinue corticosteroids.
Gastrointestinal experiences including: abdominal pain, constipation, diarrhea, dyspepsia, flatulence, nausea, vomiting.
Anemia, dizziness, edema, elevated liver enzymes and headache.
Box conatains 2 strips each of 10 ER capsules.